TBPM-PI-HBr + Ertapenem + Dummy Infusion + Dummy tablets
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Complicated Urinary Tract Infection
Conditions
Complicated Urinary Tract Infection, Acute Pyelonephritis
Trial Timeline
Jun 3, 2019 → May 27, 2020
NCT ID
NCT03788967About TBPM-PI-HBr + Ertapenem + Dummy Infusion + Dummy tablets
TBPM-PI-HBr + Ertapenem + Dummy Infusion + Dummy tablets is a phase 3 stage product being developed by Spero Therapeutics for Complicated Urinary Tract Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT03788967. Target conditions include Complicated Urinary Tract Infection, Acute Pyelonephritis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03788967 | Phase 3 | Completed |
Competing Products
20 competing products in Complicated Urinary Tract Infection